Chief Scientific Officer (5) (6) · CORCEPT THERAPEUTICS INC (CORT)

Hazel Hunt

FY2020 is the first fiscal year CompBrief holds for Hazel Hunt as a named executive officer of CORCEPT THERAPEUTICS; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$2,759,513

Salary $431,873Stock awards $0Bonus $243,000

4th of 5 named executive officers at Corcept Therapeutics by FY2020 total.

5 named officers on file for CORCEPT THERAPEUTICS, FY2020

Hazel Hunt’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 2 equity grants, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how CORCEPT THERAPEUTICS’s whole pay program stands against its peers

  • CORCEPT THERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CORT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 22, 2021 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Hazel Hunt’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Hazel Hunt compensation by year

CORCEPT THERAPEUTICS Summary Compensation Table · the one fiscal year held
In US dollars, as CORCEPT THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020
Salary$431,873
Bonus$243,000
Stock awards$0
Option awards$2,084,640
Non-equity incentive$0
Pension and deferred compensation$0
All other$0
Total$2,759,513

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CORCEPT THERAPEUTICS INC DEF 14A filed April 22, 2021, accession 0001628280-21-007363, and prior-year filings. Open the filing on EDGAR.

How this page was built: the CORCEPT THERAPEUTICS INC filed document, accession 0001628280-21-007363. Every figure is read from that document and cited to the page and table it appears in. Filed April 22, 2021.

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
Option43,750—$16.52
Option81,250—$11.35
Option8,334—$8.27
Option35,834—$15.82
Option158,334—$13.56

Per the Outstanding Equity Awards at Fiscal Year-End table in CORCEPT THERAPEUTICS INC's FY2020 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

20 Form 4 lines since the FY2020 proxy (filed April 22, 2021)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-02-27Grant or award derivative—140,000$0.00140,000
2026-02-09Exercise or conversion—150,000$3.88333,405
2026-02-09Tax withholding—77,968$41.31255,437
2026-02-09Exercise or conversion derivative—150,000$0.000
2025-02-28Grant or award derivative—140,000$0.00140,000
2025-02-11Exercise or conversion—150,000$3.29268,581
2025-02-11Exercise or conversion derivative—150,000$0.000
2025-02-11Tax withholding—85,176$68.11183,405

The 8 most recent of 20 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

CORCEPT THERAPEUTICS’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Joseph BelanoffChief Executive Officer and President (3)$5,762,102
Sean MaduckChief Commercial Officer (6)$3,196,941
Charles RobbChief Business Officer and Secretary (7)$2,914,438
Hazel Hunt · this pageChief Scientific Officer (5) (6)$2,759,513
Andreas GrauerChief Medical Officer (4)$2,063,274

The full CORCEPT THERAPEUTICS compensation record

free company brief

This page is one person within CORCEPT THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are CORCEPT THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Hazel Hunt's compensation dossier · One-time report. No refunds.